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Background and Objectives: The global trend of healthcare is to improve the quality
and safety of care for older people with cognitive disorders in their own home. There is
a need to identify how medicines management for these older people who are cared by
their family caregivers can be safeguarded. This integrative systematic review aimed to
perform the needs assessment of medicines management for older people with cognitive
disorders who receive care from their family caregivers in their own home.
Methods: An integrative systematic review of the international literature was conducted
to retrieve all original qualitative and quantitative studies that involved the family
caregivers of older people with cognitive disorders in medicines management in their
own home. MeSH terms and relevant keywords were used to search four online
databases of PubMed (including Medline), Scopus, CINAHL, and Web of Science and to
retrieve studies published up to March 2021. Data were extracted by two independent
researchers, and the review process was informed by the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA). Given that selected studies were
heterogeneous in terms of the methodological structure and research outcomes, a
meta-analysis could not be performed. Therefore, narrative data analysis and knowledge
synthesis were performed to report the review results.
Results: The search process led to retrieving 1,241 studies, of which 12 studies
were selected for data analysis and knowledge synthesis. They involved 3,890 older
people with cognitive disorders and 3,465 family caregivers. Their methodologies varied
and included cohort, randomised controlled trial, cross-sectional studies, grounded
theory, qualitative framework analysis, and thematic analysis. The pillars that supported
safe medicines management with the participation of family caregivers in home care
consisted of the interconnection between older people’s needs, family caregivers’ role,
and collaboration of multidisciplinary healthcare professionals.
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Conclusion: Medicines management for older people with cognitive disorders is
complex and multidimensional. This systematic review provides a comprehensive image
of the interconnection between factors influencing the safety of medicines management
in home care. Considering that home-based medicines management is accompanied
with stress and burden in family caregivers, multidisciplinary collaboration between
healthcare professionals is essential along with the empowerment of family caregivers
through education and support.
Keywords: aged, cognitive disorder, dementia, caregivers, family, home care services, medication therapy
management, Alzheimer disease
INTRODUCTION
Cognitive disorders consist of several neurological conditions
such as dementia and its most common subtype (70% of cases)
Alzheimer’s that influence the memory, cognition, thinking,
behaviour, and functional ability to perform activities of daily
livings. Age has been introduced as a strong risk factor for the
development of cognitive and memory disorders (1). Given that
23% of the total global burden of diseases can be attributed to
disorders among older people (≥60 years), neurological disorders
are considered one of the leading contributors (6.6%) to disease
burden in this age group (2).
Demographic transition has resulted in a significant increase
in the elderly population, bringing degenerative neurological
diseases including cognitive and memory disorders. Nowadays,
50 million people live with dementia worldwide, and the number
will most likely rise to about 150 million by 2050 (3). As the
matter of economic impact, the global estimation of the costs
of dementia treatment and care has been US $957.56 billion in
2015, which will reach US $2.54 trillion in 2030 and US $9.12
trillion in 2050 (4). The devastating impact of cognitive and
memory disorders on caregivers and family members should
be added to this economic burden (3, 5). However, the burden
of neurological disorders has been seriously underestimated by
traditional epidemiological and health statistical methods that
take into account only mortality rates rather than disability
rates (6).
Family Caregiving for Older People With
Cognitive Disorders
Cognitive and memory disorders are multifactorial and complex
healthcare conditions (7). According to the World Health
Organisation (WHO) Ministerial Conference on Global Action
Against Dementia in 2015, improvement of the quality of care
delivered to these patients has been stated as a priority given
its significance to the reduction of the global burden of these
disorders in both individual and social levels (8). There is a
huge gap in the workforce required to provide care to patients
living with long-term illnesses and behavioural health issues
(9). Therefore, development of community-based care initiatives,
families’ partnership, and consideration of institutional care
as the last care resort have been emphasised for developing
sustainable and high-quality care provision to these patients (10).
Family caregivers have the crucial role in the provision of
long-term care and support to patients (11). Involvement of
family members in designing and developing transitional care
programs from hospital to own home and provision of support
and education influences their commitment for collaboration
(12, 13). Rapid and inappropriate transition of care including
brief discharge plans, referral to the general physician or a
primary caregiver without the full engagement of families
have been shown to lead to insufficiencies in hospital-to-home
transitions (14). New approaches to care planning for older
people with cognitive disorders should include families and
informal caregivers (15). However, the caregivers of patients
with cognitive disorders often experience moderate or high
levels of care burden that impacts their health, well-being, life
satisfaction and resilience (16–18). Therefore, family caregivers
need interaction and collaborative relationship with healthcare
providers in the process of care transition to their own home
leading to more patient-centred care (19, 20).
Medicines Management in Home Care
Patients with cognitive disorders experience non-cognitive
and psychotic symptoms, behavioural disturbances, and mood
changes, which cause many challenges for both the patient and
their caregivers (21). Poorer cognition and behavioural and
psychological symptoms, impairments in performing activities
of daily living, and burden of caregiving that accompany
cognitive disorders increase the risk of admission to nursing
homes (22). Therefore, the use of medications for symptoms’
treatment among patients with cognitive disorders is associated
with the improvement of functional and cognitive outcomes,
fewer admission to nursing homes and hospitals, and the overall
mortality (23, 24).
It has been shown that more than 40% of older people
with cognitive disorders regularly use psychotropic medications
such as antidepressants and cognitive enhancers (25). However,
the rate of medication adherence among these older people
ranges from 10.7 to 38% (26), which increases the risk of
rehospitalisation after care transitions fromhospital to own home
(24). Therefore, family caregivers have the central position to
perform home-based medicines management. The burden and
distress of care in family caregivers should be reduced to improve
the quality and safety of the medication process (11, 27, 28).
Previous reviews so far have concentrated on dementia
home care by family caregivers and have not elaborated and
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specified the needs of family caregivers in home-based medicines
management (29–31). Given the lack of integrated knowledge
to inform the needs assessment of medicines management for
older people with cognitive disorders who receive care from
their family caregivers in their own home, this systematic review
of international literature aimed to find the answer to the
following question: What are the requirements of safe medicines
management for older people with cognitive disorders by family
caregivers in home care?
MATERIALS AND METHODS
Design
The systematic review of international literature was carried out
as an explicit method for collating and synthesising relevant
empirical knowledge and giving a comprehensive answer
to the research question (32). Since criteria for conducting
meta-analysis or meta-synthesis could not be met on this
research topic, an integrative review approach was chosen to
include all empirical studies with qualitative and quantitative
designs and to develop a comprehensive understanding of the
healthcare problem through the creation of a connexion between
numeric and narrative findings (33). The PICO statement was
used for framing the review question, as follows: P: family
caregivers of older people with cognitive disorders; I: medicines
management in own home; C: requirement of medicines
management identified by stakeholders; and O: safety of the
medication process.
Search Process
After the review protocol was developed and agreements on its
details were reached by the authors, four online databases that
mainly covered health sciences’ literature were searched: PubMed
(including Medline), Scopus, CINAHL, and Web of Science. It
was aimed to retrieve all empirical studies without any limitation
in the language and year of publication up to March 2021.
Inclusion criteria were all empirical studies with both
qualitative and quantitative designs that involved the family
caregivers of older patients with cognitive disorders in medicines
management in own home and were published in peer-reviewed
journal. On the other hand, reviews, commentaries, discussions,
conference proceedings, letters to editor, and empirical studies
on medicines management in acute and long-term healthcare
settings were excluded.
The authors’ previous experiences with conducting research
on medicines management and the care process for older people
with long-term mental health issues as well as a pilot search in
general databases helped with identifying appropriate keywords.
Also, a librarian in the affiliated university was approached
to ensure the accuracy of keywords and database selections.
Therefore, all probably relevant keywords and MeSH terms were
identified and were used to build search phrases for conducting
the search in titles, abstracts, and articles’ contents using the
Boolean method and the related operators (AND, OR). Cross-
referencing from articles’ bibliographies and a manual search in
well-known journals that published relevant studies helped with
improving the search coverage.
The titles and abstract of retrieved studies were carefully
screened by the authors, and full texts were read to identify
relevant studies to our review topic. However, decisions on the
inclusion or exclusion of studies based on the inclusion criteria
were through holding discussions by the authors.
Quality Appraisal and Risk of Bias
Assessment
Two authors (MV and SB-G) weremade blind to studies’ authors,
journal name, and institution and independently evaluated the
quality of each study using quality appraisal tools. They held
discussions to share the evaluation results and to decide the
inclusion and exclusion of each study.
The modified Consolidated Standards of Reporting Trials
(CONSORT) was used for the appraisal of the methods and
results sections of interventional studies. Studies with scores
≥70% of the highest score of the CONSORT checklist were
judged as high quality, 40–70% as moderate quality, 20–40% as
low quality, and <20% as very low quality (34).
The modified Newcastle–Ottawa Quality Assessment Scale
was applied (35) for the quality appraisal of observational
studies in terms of the selection of participants, comparability
of the study, and assessment of outcomes. Scores above 6, 3–
5, and below 3 were interpreted as high, moderate, and low
quality, respectively.
The Critical Review Form—Qualitative Studies (Version 2.0)
was used for assessing qualitative studies (36). It assessed studies
in terms of purpose, justification of research, theoretical and
philosophical perspectives for the design, method, sampling,
data collection, data analysis, rigour, and conclusions and
implications. Scores 1–6, 7–11, and 12–18 were interpreted as
low, moderate, and high quality, respectively.
The ROBINS tool in non-randomised studies of interventions
and observational studies was used for assessing the risk of
bias (37), which has been recommended by the Cochrane (32).
Five domains of (i) assessment of exposure, (ii) development
of outcome of interest in case and controls, (iii) selection of
cases, (iv) selection of controls, and (v) control of prognostic
variable in cross-sectional studies; seven domains of (i) selection
of exposed and non-exposed cohort, (ii) assessment of exposure,
(iii) presence of the outcome of interest at the start of the study,
(iv) control of prognostic variables, (v) assessment of the presence
or absence of prognostic factors, (vi) assessment of outcome,
and (vii) adequacy of follow-up for cohort studies; and also six
domains of (i) bias in random sequence generation, (ii) bias
in allocation concealment, (iii) bias in blinding of participants
and personnel, (iv) bias in blinding of outcome assessment,
(v) bias in incomplete outcome data, and (vi) bias in selective
outcome reporting for interventional studies were used for the
assessment. Accordingly, the authors’ judgment for risk of bias
was categorised as “low risk,” “high risk,” and “unclear risk” for
interventional studies and high risk, low risk, and probability yes
or no risk of bias for observational studies.
Data Extraction and Knowledge Synthesis
Data from the selected studies were extracted independently by
two authors (MV and SB-G) using an extraction table. The data
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TABLE 1 | The result of search and article selection process.
















(medication OR drug OR medicines OR “medicines
management” OR “medication management”) AND
(old* OR elder* OR aged* OR senior*) AND (dementi*
OR alzheimer* OR “cognitive impairment*”) AND
(family OR spouse* OR partner* OR “family care*” OR
“family nursing” OR caregiver* OR “informal care*” OR
“non-professional care*” OR partner*) AND (home* OR





123 16 11 7 7
Scopus 274 6 3 0 0
CINAHL 409 5 0 0 0
Web of
Science





3 3 3 1 1
Total 1,241 79 21 12 12
were exported into the categories of author’s name, publication
year, country, design, sample size and setting, findings, and
conclusion of home-based medicines management with the
involvement of family caregivers.
The studies identified for this review had many variations
in terms of aims, research structures, and methodological
considerations. Therefore, a meta-analysis of findings could not
be performed; and the review findings are presented narratively,
which was informed by Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement (38).
RESULTS
Search Results and Selection of Studies
The comprehensive search on the online databases and
backtracking of references led to retrieving 1,241 studies
(Table 1). After duplicates and irrelevant studies were deleted
based on independent title screening and abstract reading by
two authors (MV and SB-G), 21 studies were chosen for full text
reading (Figure 1). They were carefully read, and their contents
were checked against inclusion criteria, of which 12 studies fully
met the criteria and were entered into full-text quality appraisals
and risk of bias assessment.
Quality Assessment and Risk and Bias
Assessment
The full texts of 12 articles were assessed in terms of
methodological quality and risk of bias. The quality
assessment of the included studies has been presented in
Supplementary Tables 1–4 and Supplementary Figures 1–3.
Nine studies were classified as high quality (39–47) and three as
moderate quality (48–50), and no study had low quality.
The studies mostly were judged as having low risk of
bias for the evaluated domains (Supplementary Figures 1–3).
Accordingly, all cross-sectional studies (40, 41, 48, 50) had a low
risk of bias in the assessment of exposure and development of
outcome of interest. However, two-thirds of them had probability
high risk of bias in selection of case and controls, and half of them
had high risk of bias in control of prognostic variable.
There was one cohort study (49) that had low risk of bias
for adequacy of follow-up of cohorts, assessment of outcome
and exposure, and assessment of the presence or absence of
prognostic factors. However, it had high risk or probable high
risk of bias in the selection of exposed and non-exposed cohorts,
control of prognostic variable, and presence of outcome at start
of study.
In interventional studies, all studies (39, 42, 46) had a
low risk of bias in the reporting of selective outcomes,
incomplete outcome data, and random sequence generation.
However, two-thirds of them had a high risk or unclear risk
of bias in the blinding of personnel, participants, and outcome
assessment. In addition, all of them had an unclear risk in the
allocation concealment.
Therefore, all studies (n = 12) were included in the
data analysis and knowledge synthesis given their acceptable
methodological structure and relevance to our review topic.
Characteristics of Selected Studies
The general characteristics of the selected studies have been
presented in Table 2. They were published between 2006 and
2017, indicating that the search process encompassed a decade
research on this topic. They involved 3,890 older people with
cognitive disorders and 3,465 family caregivers.
Four studies were conducted in the United States (40–42, 48),
three studies in the United Kingdom (43–45), three studies in
Germany (46, 49, 50), and two studies in Australia (39, 47).
The studies had variations in methodologies including cross-
sectional studies (40, 41, 48, 50), randomised clinical trials (39,
42, 46), cohort (49), and qualitative studies (43–45, 47).
The studies aimed to assess for skills and adherence to home-
based medicines management (40, 43–48), interventions to
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FIGURE 1 | The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
support family caregivers (39, 42), and inappropriate medication
use and drug-related problems (41, 49, 50).
Needs Assessment of Safe Medicines
Management in Home Care
The older people participating in the studies suffered from
dementia and had various levels of cognitive impairment from
mild to severe. Also, the mean number of medications taken
by them in home care was between a minimum of 4.9 and a
maximum of 10, indicating over-medication and polypharmacy,
respectively. Overall, their adherence to medications was low;
and therefore, all older people needed and received support for
medicines management from family caregivers in home care.
Family caregivers were taken as responsible and were involved in
all interventions related to home-based medicines management
including dispensing, preparation, administration, follow-up,
and monitoring the effects and side effects of medications
(Table 3).
Older People’s Dependence on Family
Caregiving in Their Own Home
Family caregivers were mentioned to be in the best position to
accurately assess the ability and performance of older people
with cognitive impairment to manage medications and to ensure
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that the safe level of adherence to the medication regimen was
achieved (45, 48, 49). They tried to improve older people’s
independence in medicines management as much as possible
and enhance their confidence in self-care. Older people tried
to learn about medications and remember regimen using the
visual recognition of medications, linking medications’ taking
to life routines, memory aids as board notices, and dose
administration aids (47). However, they were unable to perform
the medication process safely (45, 48, 49). They showed worse
functions in medicines management tasks, including timing,
dosing, preparation and naming medications, and medication
intake, due to forgetfulness and administration of medications
(48, 49). They also relied heavily on their family caregivers to
regularly supply their medications given that no such a care
option was available by healthcare providers in home care (47).
Therefore, family caregivers were on the duty of older people
care between 16 and 24 h a day on average for the provision
of support (40), which influenced the quality and safety of the
medication process. The greater the level of cognitive impairment
and awareness deficit, the greater the support for the preparation
and administration of medications was needed. Consequently,
those older people who received more support in their activities
of daily living from their family caregivers had greater adherence
to medications than those who received less support (48).
Family Caregivers’ Concerns and
Strategies for Medicines Management
Medicinesmanagement wasmentioned as a complex process that
required adopting routines. Family caregivers had no structurally
defined role and did not receive education and support to
perform medicines management tasks. Insufficient problem-
solving skills, poor cognitive and memory function, and co-
morbidities in family caregivers who had to manage their own
medications at the same time enhanced the burden of care and
the possibility of medication errors (40, 47). Also, caregivers’
age was associated with deficiency in medicines management in
terms of knowledge of medications and how to carry out the
medication process (40). Additionally, the emotional burden of
care encompassed having the obligation to take responsibility of
the medication process for someone else and prioritising others’
health on their own health (43). In this respect, decision making
by family caregivers on the administration of sleep medications
to older people to promote rest in family caregivers created an
ethical challenge as it counterposed the health needs of family
caregivers and those of older people who needed advocacy (44).
Taking medication at different times of the day and supply
of medications were main challenges from family members’
perspectives (43). Family caregivers were responsible for
monitoring supplies from various prescriptions and timely
refilling medications. Therefore, changes in prescriptions
were added to the burden of care regarding taking correct
medications (45).
Medication administration also enhanced their anxiety and
care burden given the possibility of error during filling the dosette
box. They tried to prevent medication errors by undertaking the
task when they felt fresh and had more readiness to perform
complex caring tasks (45, 47). Missed doses because of older
people’s reluctance to take medications were another concern.
To overcome this barrier, they tried to inform older people and
share information with them to involve them in decision making
regarding medications to feel control over their own medications
(45). However, adherence was difficult, as not all older people
could understand the significance of taking medications, because
of the complexity of regimens and not all medications taken
regularly had a visible impact on their symptoms (43, 47).
Explaining the reason for the administration of medications
for relieving visible signs and symptoms reduced older people’s
resistance to adherence (44, 47). Regular and frequent visits and
reminders via phone calls by those family caregivers who did
not live with older people ensured that medications were taken
timely (45).
Family caregivers felt frustration over the ineffectiveness of
medications on improving the behaviour and memory of older
people (43). They monitored the effectiveness and side effects of
medications through observing older people’s behaviour such as
being tired and accordingly made judgments (45). They also were
worried about taking over the tasks of medicines management
and communicating routines to other family members or
healthcare providers in emergency situations and hospitalisation.
They used their mobile phones and created a backup of the list of
medications and asked another family member to save it (47).
Medicines Management Issues in Home
Care
Rapid changes in cognitive abilities, complexity of medications,
side effects of medications, and transition of care to the hospital
and then back to own home hindered family caregivers in
undertaking home-based medicines management safely (47).
Also, insufficient use (21%) of healthcare services such as
physiotherapist, occupational therapist, and speech therapy
indicated inadequate or limited access to such services, which in
turn led to overreliance on medication use for relieving health
issues (46). About 55% of caregivers made at least onemedication
error, and an average of three deficiencies in medication was
reported by 92.3% of them. Medication reconciliation identified
56% medication errors in terms of wrong time, forgetting
to take the medication, losing pills, refilling prescriptions,
mixing medications inappropriately, discontinuing medications
without consultation, not taking medication on an empty
stomach, and dumping pills into water (40). In another
study, administration and compliance issues (60%), all potential
drug-related interactions (17%), inappropriate selection (15%),
dosage (6%), adverse drug events (2.5%), inappropriate time of
application (40%), inappropriate combinations and interactions
with moderate severity (35%), lack or outdated medication
list (25%), inappropriate medication (23%), forgetting to take
medications (18%), inadequate storage of medications (44%),
and inappropriate storage as poor traceability, being exposed to
moisture or light, and being scattered around the house (41%)
were reported (50).
In addition to donepezil and other cognitive-enhancing drugs
such as cholinesterase inhibitors and anticholinergic drugs, older












































To investigate the cognitive status of
patients, skills for medicines
management, adherence to
medications, and amount of help
received from family caregiver
Cross-sectional 27 (male/female) older people
(>65 years) with Alzheimer’s
and 20 (male/female) healthy
older people, dyad caregivers
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relatives in home care
Complexity of the medication
regimen, behaviour of adherence
using pill counts, predicated
adherence, medicines management
tasks, prediction of task, awareness
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Acceptable level of adherence
to medications but
ineffectiveness of some
strategies by family caregivers
to ensure sufficient adherence
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of older people with Alzheimer’s
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The need to evaluate the
necessity and
appropriateness of
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to reduce the risk of
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comparison with healthy older
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To explore the perspectives of older
people with dementia and their
family carers regarding medicines
management and compare them
with those of healthy older people
Grounded
theory
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To identify the perspectives of family
caregivers of older people with
dementia about medication
management in home care
Thematic
analysis
9 family caregivers (spouse and
child)
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To explore the experiences of family
caregivers about how to make
medicines management more




9 (male/female, 45–86 years)
family caregivers (spouse and
child) and 5 older people with
dementia (male/female, 81–93
years)
Activities related to medicines
management and problems
experienced by caregivers
Complexity of care and
decision making for medicines
management, medication
supplies, adherence to the
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information and advice, older
people’s autonomy
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To analyse the various aspects of
dementia care including medicines
management for older people in
own home after receiving
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individualised care to improve
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To identify the prevalence and type
of drug-related problems and
associated factors among older
people with dementia in home care
after the implementation of
collaborative dementia care
management
Cross-sectional 446 (>79 years) older people
with dementia (male/female),
family caregivers (n = not
specified)
Medication assessment: medication
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Areas of need to support for home-based
medicines management by family
caregivers
Cotrell et al. (48) Mild–moderate Not specified 17–100% Yes Checking and setting up pill box, timing,
dosing, naming and preparation of
medications, administration of medications
Brodaty et al. (39) Moderate–
moderately
severe
Not specified Not specified Yes Dosage, preparation and administration of
medications, assessing effectiveness of
medications, concurrent medications use,
alcohol–medication interaction, adverse events
Lau et al. (41) Very mild–severe 4.9 Not specified Yes Not specified
Erlen et al. (40) Moderate 10 Acceptable level Yes Supply, storage, timing, being reminded to take
medications, mixing, administration of
medications
Fiss et al. (49) Mild and
suspicious
6.8 No Yes Preparation and administration of medication
While et al. (47) Not specified Not specified Yes Yes Filling dosette box, dosage, supply,
administration of medications, monitoring side
effects, tracking medications and renewal
Poland et al. (44) Not specified Not specified Not specified Yes Preparation, mixing, medication administration
based on the older people’s need,
communicating medication-related issues to
healthcare providers, deciding on the
discontinuation of medications, monitoring
effects and side effects
Smith et al. (45) Various 7 Low level Yes Supply, refill, filling dosage box, timing,
monitoring effects and side effects,
communicating with healthcare providers
Thyrian et al. (46) Mild Not specified Not specified Yes Preparation and administration of medication
Lingler et al. (42) Mild 10 Low Yes Pharmacy pickup, storage, pillbox, medication
administration (OTC) over the counter
medications, receiving support from local






Not specified Not specified Low Yes Supply, timing, administration of medication,
deciding on the discontinuation of medications
Wucherer et al.
(50)
Mild–severe >5 Low Yes Storage, timing, medication list preparation,
administration
people took many medications for cardiovascular, nervous,
digestive, and respiratory disorders; osteoporosis; joint pain; and
mental and psychiatric health issues (45, 46, 49, 50). Taking more
medications was associated with more medication deficiencies
and errors in home care (40). Therefore, over-medication as
taking many medications at the same time and polypharmacy
as taking more than five medications increased the risk of
potentially inappropriate medications use and were considered
safety concerns. They potentially worsened behavioural and
psychological symptoms and made the family caregivers worried
about medications’ effectiveness and side effects (41, 47, 49, 50).
Increasing the total number of medications increased the risk
of potentially inappropriate medication use, as follows: five to
six medications, 6.44 times; and seven to eight medications, 12.6
times (41).
The presence of co-morbidities including hypertension,
incontinence, depression, and anxiety in these older people
increased potentially inappropriate medication use, as 15%
of older people had at least one potentially inappropriate
medication use with the following medications: oral oestrogens
(14%), muscle relaxants and antispasmodics (14%), fluoxetine
(13%), short-acting nifedipine (11%), and doxazosin (7%) (41).
In another study by Thyrian et al. (46), about 19.3% had one,
2.3% two, and 0.2% three potentially inappropriate medications.
In the study by Fiss et al. (49), 27% received potentially
inappropriate medications, and 20% received medications that
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were contraindicated in these patients including antidepressants
(mostly amitriptyline), hypnotics (zolpidem), and anxiolytics
(diazepam). In the study of Wucherer et al. (50), 92.8% had
at least one drug-related problem, 64% had one to three drug-
related problems, and 27% had four to seven drug-related
problems. Also, 8% of older people received medications with
a high dosage, and 6% reported adverse drug events related
to a prescribed medication. The most frequently prescribed
potentially inappropriate medications were antidepressants,
benzodiazepines, and analgesics. On the other hand, the
appropriate use of Fybogel as a laxative for relieving constipation
as a minor health issue reduced physical and emotional distress
among older people (44).
Both polypharmacy and potentially inappropriate medication
use enhanced the risk of falls (72%) and adverse drug effects
considering that these older people were sensitive to cognitive
impairments induced by medications including confusion,
nightmare, agitation, and depression, which enhanced the risk
of admission to the nursing home (41, 49, 50). Given the
cost of admission to nursing homes and the reported survival
rate in there in the United Kingdom and Australia, the safety
of home care in the hands of family caregivers depended on
care supervision by healthcare professionals to monitor the
effects and side effects of medications and help with resolving
medication-related issues that were beyond the abilities of family
caregivers (39).
Support for Medicines Management in
Home Care
Listening to family caregivers’ concerns and provision of verbal
and written information at their understanding were important,
but more assistance with problem solving for managing
medications in home care was required (40, 43). Physicians,
pharmacists, nurses, older people, and family caregivers should
coordinate medication-related care, as it created the feelings
of safety, confidence, and assurance in home care (46, 47).
Coordinated actions from various healthcare providers such as
compliance packs prepared by pharmacists and support by nurses
with pro re nata (PRN) medications specifically were needed
(43). Family caregivers needed a structured list to keep track
of medications when renewal was needed, and authorisation of
prescription could be granted via phone calls. Inconsistencies in
collaboration by healthcare providers led to frustration and stress
(44, 45, 47). Also, absence of the medication list contributed to
the high number of administration and compliance problems
(50). For example, home visits by the nurse or social worker
along with telephone calls to support the family caregivers’ role in
medicines management in terms of preparation, administration,
and follow-up reduced the number of problems and deficiencies
in medicines management in terms of dropping or losing pills,
forgetting to take medications, dosage issues, and wrong times of
medication administration (42).
Medication review by healthcare professionals was required
to reduce the complexity of the medication regimen, leading
to changes in medications and replacing them with those that
could be administered with fewer doses and administering times,
which consequently could improve adherence (43). A home-
based medication review on prescribed and over-the-counter
(OTC) medications not only improved medication compliance
but also enhanced appropriate storage of medications (50). It
should go beyond asking the patient about taking and not taking
medications and should encompass dosage, effects, and side
effects of medications (40, 43, 50). It could help with rectifying
the misperception in family caregivers who deprescribe and stop
medication could endanger the quality of life of loved ones
(43, 44). The result also should be shared with other healthcare
providers to enable care coordination and reduce the burden of
sharing complex information by families and older people (43).
Considering the effect of progression of cognitive impairment
on learning and developing skills for the medication process,
family caregivers should be involved in the hospital discharge
plan and be informed of changes in the medication regimen.
Family caregivers could influence older people’s beliefs and
preferences to take medications and adhere to the medication
process and were able to monitor and report medications’ side
effects (45, 47).
A supportive carer–healthcare professional relationship was
needed to improve their knowledge about medications and
enhance their power and feeling of control. Family caregivers
felt despair in communicating medication-related issues and
getting support from healthcare providers, as they felt that
healthcare providers put all responsibility of care on their
shoulder and did not advise about the practical aspects of
medicines management (44, 47). Given that older people with
cognitive impairment were unable to communicate their needs,
family caregivers wanted to learn about identifying older people’s
needs to medications through observations and interpretation of
behavioural clues (44).
Knowledge of medications was important; and family
caregivers preferred to discuss with healthcare providers about
rationale for prescription and the balance between the benefits,
side effects, and harms of medications. They needed to be
empowered to be able to monitor and report the effect of the
medication regimen, side effects, and adverse drug reactions
(44, 47). The role of family caregivers in the control of medication
use and making decisions on their continuance of use was
unclear, as no healthcare provider was accessible to monitor
medications for pain relief, hypertension, osteoporosis, diabetes,
and eye problems as well as PRN medications (44). Family
caregivers proactively sought information about medications
through reading packages, searching the internet, and making
phone calls to healthcare providers regarding the type of
medication, dosage, and related side effects (45). However,
medication packaging was not helpful given difficulties in
understanding and the multiple use of medications. Information
should be simplified based on culture and language abilities and
be interpreted to become appropriate to information-seeking
needs particularly for the most common side effects and how
to make decisions on them in the absence of access to expert
knowledge (43–45).
A summary of the review findings regarding the needs
assessment of safe medicines management for older people with
Frontiers in Neurology | www.frontiersin.org 10 September 2021 | Volume 12 | Article 694572
Vaismoradi et al. Medicines Management in Home Care
FIGURE 2 | The needs assessment of safe medicines management for older people with cognitive disorders who are cared by their family caregivers in own home.
cognitive disorders who are cared by their family caregivers in
their own home is presented in Figure 2.
DISCUSSION
This systematic review with an integrative approach helped with
removing the gap of knowledge and enhanced our understanding
of needs assessment of home-based medicines management
for older people with cognitive disorders who were cared
by their family caregivers. The review findings indicated the
areas of needs of older people with cognitive disorders and
their family caregivers in home care and what the role of
healthcare professionals could be to help with safeguarding
medicines management.
Older people with cognitive disorders preferred to remain
independent as much as possible and to gain more control
over their own medications. Family caregivers complied with
older people’s preferences, but progression of the disease and
memory issues were barriers to retain independence. Therefore,
the burden of medicines management was put on the shoulder
of family caregivers who themselves needed support to manage
medications for their own underlying health conditions and
to reduce care stress. Collaborative strategies for medication
management depend on the disease stage, and physical and
mental capacity of older people as well as collaboration
inputs by family caregivers (51). According to the statement
by the United Nations (UN) and the WHO, facilitation of
access to rehabilitation and palliative care is considered an
ethical responsibility of healthcare systems. Also, healthcare
professionals have the duty to alleviate pain and suffering
among older people with physical, psychosocial, or spiritual
sources irrespective of the curability of the disease (52). Any
intervention aiming at the reduction of frailty among older
people enhances benefits for individuals, families, and the society
as they experience less cognitive or functional decline and
have lower mortality rates (53). Family caregivers take different
roles during the care process as caregivers, welfare enhancers,
facilitators, apprentices, and minimisers/managers of suffering.
They carry out many tasks and are responsible for the continuity
of care and making decisions at the end of life (54). In the
caregiving relationship, burden, resilience, needs, and rewards
are interrelated (55). Female andmale caregivers take on different
tasks, which come with gender-specific care burden and health-
related concerns. Sex- and gender-based analyses regarding
caregiver’s burden are limited. In terms of preparedness, being
female and cohabiting with the patient have been associated
with a higher level of preparedness to take over the caregiver’s
role (56). All caregivers achieve lower scores on physical and
mental health measures than the general population (57). Studies
assessing caregiver’s burden have found higher burden or care-
related distress among female caregivers as well as significantly
higher levels of depression in female caregivers compared with
their male counterparts. In terms of mental health, women report
two times higher depression, but there have been suggestions
within the international literature that men’s experiences of
depression may manifest with symptoms that are not currently
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included in traditional depression scales. In terms of physical
health, female caregivers experience better sleep quality and
significantly less co-morbidity, but male caregivers demonstrate
biomarkers for increased thrombosis and inflammation risk (58).
Prolonged grief disorder is predicted by the poor physical and
mental health status before bereavement (57). Caregiver’s health
impacts the patient’s quality of life and dying. Caregiver’s capacity
and preparedness for the provision of care can ensure quality of
life, care, and death for older patients with memory disorders.
Caregiver’s fair-to-poor health status can predict non-elective
hospital visits as well as hospital death (59).
Despite the family caregivers’ crucial role, safety of the
medication process could not be fully preserved, and medication
errors and non-adherence to the medication regimen were
reported in home care. The full compliance with the safety
initiatives of home-based medicines management needed the
support of healthcare professionals. Healthcare professionals
should reduce over-reliance on medications; prevent
medication errors; manage over-medication, polypharmacy,
and inappropriate medication use; and monitor the effects and
side effects of medications. Safety of medicines management
in home care required that healthcare professionals coordinate
discharge planning and care transition, attend home visits,
and share information between other healthcare providers
involved in home care. Moreover, a supportive and professional
family caregiver–healthcare relationship with an emphasis on
considering family caregivers’ concerns, their education, and
empowerment to safely perform the medication process was
needed. The accepted perspective is that older people with
cognitive impairment living in the community need coordinated
and flexible care process (60–62). An early integration of
holistic palliative care approaches that encompass medicines
management initiatives into home care should be included
from the beginning of the illness (63, 64). The Lancet’s call for
action specifies “as the world population ages, comorbidity
also increases, a shift from a health system centred in medical
specialties to person-centred care is required.” This call also
includes the provision of education and support to family
caregivers, whose role in providing the best care for people with
memory disorders should not be overlooked (65).
The heterogeneity of the studies included in this systematic
review in terms of methods and aims hindered conducting
a meta-analysis. Also, a few studies were retrieved during
the search process, indicating the insufficient number of
empirical studies. Nevertheless, this review provides an
overview of international knowledge about home-based
medicines management for older people with cognitive
disorders by their family caregivers and aspects that should
be investigated in future studies. Clinical trials are needed
to improve our understanding of the effect of home-based
medicines management interventions with the participation of
family members on the quality and safety of care. Equally
significant are the realist evaluations of any medicines
management initiatives or educational activities, which
provide a framework for understanding how the context
and underlying mechanisms affect the pattern and outcome of
the selected intervention.
CONCLUSION
This integrative systematic review demonstrated that medicines
management in home care was systematically overlooked adding
to caregiver’s burden and endangering the safety of older
people. Family caregivers’ abilities in the provision of care
to older people with cognitive impairment could not cover
all aspects of home-based medicines management. Therefore,
the burden of medicines management in home care can be
reduced through sharing the responsibility of safeguarding
medicinesmanagement between family caregivers and healthcare
professionals to be able to safely respond to older people’s
care needs.
Healthcare professions involved in home care are expected
to proactively assess and meet older people’s needs for safe
medicines management in home care and relieve the great
amount of stress and burden experienced by family caregivers.
Consideration of family caregivers’ concerns, continuous
communication with them and provision of information about
medications, discussion about medicines management strategies,
empowerment of older people with memory disorders and
their caregivers through education, and multidisciplinary
collaboration have been emphasised.
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